Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle VaccineJulio Carrera Montoya, Joseph Torresi, Simon Collett et al.|Organoids|2024Cited by 12
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P. Clark, Gregor Ebert, Margaret Littlejohn et al.|Cell Death and Disease|2021Cited by 11
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Joseph Torresi, Daniel Fernandez‐Ruiz et al.|npj Vaccines|2026Cited by 3
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Joseph Torresi, William R. Heath, Linda Earnest et al.|Research Square|2024Cited by 2
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59Linda Earnest, Joseph Torresi, Daniel Fernandez‐Ruiz et al.|SSRN Electronic Journal|2024Cited by 0